Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed, Refractory Multiple Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03338972
What this trial is testing

Immunotherapy With BCMA CAR-T Cells in Treating Patients With BCMA Positive Relapsed or Refractory Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
Fred Hutchinson Cancer Center 28
Early research (Phase 1)Looking for participantsNCT07255898
What this trial is testing

BL-M24D1 in Patients With Relapsed or Refractory Multiple Myeloma and Other Hematologic Malignancies

Who this might be right for
Multiple MyelomaHematologic Malignancies
Sichuan Baili Pharmaceutical Co., Ltd. 33
Early research (Phase 1)Looking for participantsNCT05650632
What this trial is testing

Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
AbbVie 210
Testing effectiveness (Phase 2)WithdrawnNCT04150692
What this trial is testing

Escalation of Daratumumab Frequency Following Biochemical Progression in Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Washington University School of Medicine
Testing effectiveness (Phase 2)WithdrawnNCT03701321
What this trial is testing

Daratumumab, Bortezomib, and Dexamethasone With or Without Venetoclax in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT01496118
What this trial is testing

Study of the Combination of Panobinostat and Carfilzomib in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
SCRI Development Innovations, LLC 80
Testing effectiveness (Phase 2)Looking for participantsNCT06292780
What this trial is testing

A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)

Who this might be right for
Relapsed/Refractory Systemic Light Chain Amyloidosis
Regeneron Pharmaceuticals 220
Testing effectiveness (Phase 2)Ended earlyNCT00352742
What this trial is testing

ATN-224 and Bortezomib in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Attenuon 46
Testing effectiveness (Phase 2)UnknownNCT03312205
What this trial is testing

CAR-T Cells for Relapsed or Refractory Haematopoietic and Lymphoid Malignancies

Who this might be right for
LeukemiaLymphomaMultiple Myeloma of Bone (Diagnosis)
Hebei Senlang Biotechnology Inc., Ltd. 50
Testing effectiveness (Phase 2)Study completedNCT00814541
What this trial is testing

PAD. ICORG 05-01, V11

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Cancer Trials Ireland 53
Early research (Phase 1)Looking for participantsNCT06084962
What this trial is testing

DeepTag-GPRC5D Targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple Myeloma

Who this might be right for
Relapse/Refractory Multiple Myeloma
He Huang 40
Large-scale testing (Phase 3)Study completedNCT03859427
What this trial is testing

A Study Comparing Once-weekly vs Twice-weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Amgen 454
Not applicableLooking for participantsNCT06961669
What this trial is testing

Intravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell Lymphoma

Who this might be right for
Lymphoblastic LeukemiaRelapsed or Refractory Multiple Myeloma (RRMM)
Anhui Provincial Hospital 18
Early research (Phase 1)Active Not RecruitingNCT05259839
What this trial is testing

Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused Etentamig (ABBV-383) in Combination With Anti-Cancer Regimens for the Treatment of Adult Participants With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
AbbVie 283
Early research (Phase 1)Active Not RecruitingNCT05286229
What this trial is testing

Assess Adverse Events and Change in Disease State of Intravenously (IV) Infused Etentamig (ABBV-383) of Adult Participants With Relapsed or Refractory Multiple Myeloma in Japan

Who this might be right for
Relapsed/Refractory Multiple Myeloma
AbbVie 8
Testing effectiveness (Phase 2)UnknownNCT05719701
What this trial is testing

Evaluate the Safety, Tolerability, and Efficacy of ICP-490 in Patients With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Relapsed and/or Refractory Multiple Myeloma
Beijing InnoCare Pharma Tech Co., Ltd. 80
Not applicableEnrolling By InvitationNCT05332054
What this trial is testing

Long-Term Follow-up Study

Who this might be right for
Lymphoma, Non-HodgkinRelapsed Non-Hodgkin LymphomaRefractory B-Cell Non-Hodgkin Lymphoma+7 more
Caribou Biosciences, Inc. 150
Testing effectiveness (Phase 2)Study completedNCT00795769
What this trial is testing

Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+101 more
Fred Hutchinson Cancer Center 49
Testing effectiveness (Phase 2)Looking for participantsNCT05714839
What this trial is testing

Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments

Who this might be right for
Multiple Myeloma
GlaxoSmithKline 123
Testing effectiveness (Phase 2)Ended earlyNCT00765102
What this trial is testing

Trial of Romidepsin and Bortezomib for Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 32
Next Page